Applied Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
APLT Nasdaq 2830 www.appliedtherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Applied Therapeutics, Inc.

Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media? - Jan 8th, 2025 12:50 pm
Here’s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10 - Jan 6th, 2025 2:13 pm
Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data - Dec 20th, 2024 10:15 pm
Applied Therapeutics Appoints John H. Johnson as Executive Chairman - Dec 20th, 2024 12:00 pm
Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely? - Dec 3rd, 2024 1:22 pm
Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says - Dec 2nd, 2024 5:16 pm
Company News for Dec 2, 2024 - Dec 2nd, 2024 2:11 pm
Applied Therapeutics CRL a ‘major setback,’ says William Blair - Nov 30th, 2024 11:40 am
Applied Therapeutics downgraded to Sector Perform from Outperform at RBC - Nov 30th, 2024 10:30 am
FDA Rejects Applied Therapeutics' NDA for Govorestat, Citing Flaws; Shares Plunge 76% - Nov 29th, 2024 8:56 pm
Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More - Nov 29th, 2024 6:51 pm
Top Midday Decliners - Nov 29th, 2024 5:58 pm
Sector Update: Health Care Stocks Rise in Afternoon Trading - Nov 29th, 2024 5:49 pm
Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says - Nov 29th, 2024 5:15 pm
Applied Therapeutics Stock Plummets 73%. The FDA Delivers This Crushing Blow. - Nov 29th, 2024 3:48 pm
Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug - Nov 29th, 2024 3:06 pm
Applied Therapeutics' Govorestat Faces Unclear Regulatory Path After FDA Rejection, RBC Says - Nov 29th, 2024 2:41 pm
RBC downgrades Applied Therapeutics as FDA rejects Govorestat, hacks price target - Nov 29th, 2024 1:46 pm
APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA - Nov 28th, 2024 3:13 pm
Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat - Nov 28th, 2024 12:02 pm